Kyntra Bio, Inc. (KYNB): EPS (Basic)
$45.37
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $45.37 | n/m | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | -$11.89 | n/c | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | -$2.92 | n/m | 2025-03-17, From 2023-01-01 |
| 2022-12-31 | -$3.14 | n/m | 2024-02-26, From 2022-01-01 |
| 2021-12-31 | -$3.14 | n/m | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | -$2.11 | n/a | 2023-02-27, From 2020-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Kyntra Bio, Inc. (KYNB) | 2025-12-31 | $45.37 | n/m |
| Filana Therapeutics, Inc. (FLNA) | 2025-12-31 | -$1.88 | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | -$2.65 | n/m |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | -$2.93 | n/m |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | -$1.48 | n/m |
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | -$1.58 | n/m |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | -$5.84 | n/m |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | -$1.04 | n/m |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | -$0.75 | n/m |
Compare KYNB, FLNA, CAMP, AARD side by side · Screen every company in Pharmaceutical Preparations ↗